InMode Ltd.

NASDAQ (USD): InMode Ltd. (INMD)

Last Price

16.50

Today's Change

+0.34 (2.10%)

Day's Change

16.059 - 16.84

Trading Volume

1,389,129

Profile
INMD

Exchange:  NASDAQ Global Select NASDAQ Global Select

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Moshe Mizrahy Mr. Moshe Mizrahy

Full Time Employees:  581 581

IPO Date:  2019-08-08 2019-08-08

CIK:  0001742692 0001742692

ISIN:  IL0011595993 IL0011595993

CUSIP:  M5425M103 M5425M103

Beta:  2.17 2.17

Last Dividend:  0.00 0.00

Dcf Diff:  -18.46 -18.46

Dcf:  34.96 34.96

Description

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Address

Tavor Building,
Yokne'am, 2069206, IL

972 4 909 6313

http://www.inmodemd.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment